Intake estimation of horses grazing tall fescue (Lolium arundinaceum) or fed tall fescue hay.

Six mature geldings of light horse breeds (557 ± 37 kg) were randomly assigned to a nontoxic endophyte-infected tall fescue hay (n = 3) or pasture treatment (n = 3) in a crossover design with 14-d periods to estimate DMI with alkane markers and to compare DMI of hay and pasture. When fed pasture, horses were housed in stalls from 0700 to 1300 h daily with access to water and then grazed pasture as a group in a single 0.4 ha pasture from 1300 to 0700 h. When fed hay, horses were maintained individually in stalls and given access to hay ad libitum from 1300 to 0700 h. All horses were individually fed 225 g oats twice daily treated with hexatriacontane (C36; external marker) and fecal samples were collected at 0700 and 1900 h on d 10 to 14. Fecal samples were mixed, dried, subsampled, and analyzed for tritriacontane (C33) and hentriacontane (C31) as internal markers and C36 as the external marker using gas chromatography. Estimated hay DMI using either C33 (1.75 kg/100 kg BW) or C31 (1.74 kg/100 kg BW) as internal alkane marker did not differ (P = 0.55) from measured hay DMI (1.70 kg/100 kg BW). Pasture DMI and DM digestibility (DMD) estimated with C31 (2.24 kg/100 kg BW and 53.1 g/100 g DMI) or with C33 (2.34 kg/100 kg BW and 56.2 g/100 g DMI) was greater (P = 0.05) than hay DMI and DMD (1.74 kg/100 kg BW and 44.5 g/100 g DMI). Intake estimated with C33 or C31 did not differ (P = 0.35) during hay or pasture. In conclusion, alkanes can be used to estimate pasture or hay DMI and DMD, and pasture intake exceeded hay intake when offered ad libitum.

Effect of dietary boron on immune function in growing beef steers.

Thirty-six Angus and Angus x Simmental cross steers (initial BW 269.5 +/- 22.3 kg) were used to determine the effects of dietary boron (B) on performance and immune function. Steers were fed on one of the three dietary treatments: (i) control (no supplemental B; 7.2 mg B/kg DM), (ii) 5 mg supplemental B/kg DM and (iii) 50 mg supplemental B/kg DM, from sodium borate for 78 days. Supplementation of dietary B had no effect on body weight (BW) gain, feed intake or gain:feed during the study. Jugular blood samples were collected prior to feeding on days 28, 63 and 77 for plasma-B analysis. Supplementation of dietary B increased (p < 0.001) plasma B-concentration in a dose-responsive manner. Furthermore, plasma B-concentration was correlated (p < 0.001; R(2) = 0. 95) to daily B-intake (mg B/day). Jugular blood was also collected, from an equal number of steers from each treatment, on day 42 or 44 for determination of in vitro production of interferon-gamma and tumour necrosis factor-alpha from isolated monocytes and assessment of lymphocyte proliferation. Dietary B did not affect T- or B-lymphocyte proliferation or in vitro cytokine production from monocytes. On day 49 of the study, the humoral immune response was assessed by i.m. injection of a 25% pig red blood cell (PRBC) solution for determination of anti-PRBC IgG and IgM titre responses. Boron-supplemented steers had greater (p = 0.035) anti-PRBC IgG titres than controls on day 7 but not on day 14 or 21 post-injection. Anti-PRBC IgM titres did not differ throughout the sampling period. Results from this study indicate that supplemental B had minimal effects on immune function and did not affect performance of growing steers.

Effect of selenium supplementation and source on the selenium status of horses.

This study was conducted to determine the effect of Se supplementation and source on the Se status of horses. Eighteen 18-mo-old nonexercised horses were randomly assigned within sex to 1 of 3 treatments: 1) control (CTRL, no supplemental Se, 0.15 mg of Se/kg of total diet DM); 2) inorganic Se (INORG, CTRL + 0.45 mg of Se/kg of total diet DM from NaSeO3); or organic Se [ORG, CTRL + 0.45 mg of Se/kg of total diet DM from zinc-L-selenomethionine (Availa Se, Zinpro, Corp., Eden Prairie, MN)]. Horses were acclimated to the CTRL diet (7.1 kg of DM alfalfa hay and 1.2 kg of DM concentrate per horse daily) for 28 d. After the acclimation period, the appropriate treatment was top-dressed on the individually fed concentrate for 56 d. Jugular venous blood samples were collected on d 0, 28, and 56. Middle gluteal muscle biopsies were collected on d 0 and 56. Muscle and plasma were analyzed for Se concentrations. Glutathione peroxidase activity was measured in muscle (M GPx-1), plasma (P GPx-3), and red blood cells (RBC GPx-1). Data were analyzed as a repeated measures design. Mean plasma Se concentration on d 28 and 56 was greater (P < 0.05) for Se-supplemented horses compared with CTRL horses, and tended (P < 0.1) to be greater in ORG vs. INORG on d 28. Mean muscle Se concentration and P GPx-3 activities increased (P < 0.05) from d 0 to 56 but were not affected by treatment. Mean RBC GPx-1 activity tended to be greater (P < 0.1) in ORG than INORG or CTRL horses on d 28, and tended to be greater (P < 0.1) for INORG compared with ORG horses on d 56. Mean RBC GPx-1 activity of INORG and ORG horses was not different from that of CTRL on d 56. Mean M GPx-1 activity decreased (P < 0.01) from d 0 to 56. In conclusion, zinc-L-selenomethionine was more effective than NaSeO3 at increasing plasma Se concentration from d 0 to 28; however, both supplemental Se sources had a similar effect by d 56. No difference in Se status due to Se supplementation or source could be detected over a 56-d supplementation period by monitoring middle gluteal muscle Se, M GPx-1, or P GPx-3. Results for RBC GPx-1 also were inconclusive relative to the effect of Se supplementation and source.

Evidence supporting an increased presence of reactive oxygen species in the diseased equine joint.

Reactive oxygen species (ROS) are capable of degrading many components of the joint in the presence of insufficient antioxidant defences, and as a result have been implicated in the pathogenesis of joint disease in horses. However, to our knowledge, evidence of ROS occurring in diseased joints of horses has not been reported. The objective of this experiment was to compare differences in synovial fluid protein carbonyl content (as a marker of oxidative modification of synovial fluid proteins by ROS) and the antioxidant status of synovial fluid between clinically normal and diseased equine joints. Synovial fluid was collected from the metacarpophalangeal, metatarsophalangeal, carpal and tarsal joints of 4 horses, age 2-5 years, as controls, and from diseased joints (metacarpophalangeal, metatarsophalangeal, carpal, tarsal and/or femoropatellar) of 61 horses, age 2-5 years. Synovial fluid protein carbonyl content was higher (P<0.01) in diseased joints as compared to controls. Antioxidant status of synovial fluid from diseased joints was higher, but not significantly, than that of controls (P = 0.0595). These findings require further study to determine their contribution to the overall disease process.

The effect of initiation of exercise training in young horses on vitamin K status.

Twelve Quarter Horses, 18 to 24 mo of age and having an average body weight of 460+/-12 kg, were randomly assigned to one of two exercise treatments (control and exercise) to study the effect of initiation of exercise training in young horses on vitamin K status. The control treatment consisted of hand-walking the horses 7 min/d and 5 d/wk for 180 d. Exercise consisted of the following treadmill exercise regimen: 2 min at 4.5 to 5.4 m/s, 3 min at 13.4 to 14.3 m/s, and 2 min at 4.5 to 5.4 m/s on 5 d/wk for 180 d. Both groups were allowed free access to brome grass hay (273 mg of phylloquinone/100 g) individually. Additionally, the exercise group was fed .45 kg of a grain-mix concentrate (40 mg of phylloquinone/100 g) on the days they were exercised. Jugular venous blood samples were collected at d 0, 30, 60, 90, 120, 150, and 180. Blood samples were analyzed for total serum osteocalcin and vitamin K status via the hydroxyapatite binding capacity of serum osteocalcin calculated as follows: Hydroxyapatite binding capacity of serum osteocalcin = [(total serum osteocalcin - serum osteocalcin following extraction of serum with hydroxyapatite)/total serum osteocalcin] x 100. All horses were killed with an overdose of sodium pentobarbital on d 180. Computed tomographic osteoabsorptiometry was used to measure relative bone density distribution on the surface of the distal radial carpal bone, proximal third carpal bone, and the distal third metacarpal condyle. Relative bone density distribution was measured in Hounsfield units and categorized as low-, medium-, and high-density bone corresponding to 800 to 1,199, 1,200 to 1,299, and 1,300 to 3,000 Hounsfield units, respectively. Carpal and metacarpophalangeal joints were assigned a score of 0 (normal) to 3 (severe) that reflected the presence and severity of joint lesions. Hydroxyapatite binding capacity of serum osteocalcin and serum osteocalcin were unchanged over the 180-d period in both groups. Exercised horses had a higher percentage of high density bone (P < .01) and a lower percentage of low density bone (P < .01) on the surface of the third metacarpal condyle and a higher cumulative gross lesion score (P < .01) in the metacarpophalangeal joint than controls. There were no differences between treatments in relative bone density distribution in the carpal bones, or cumulative gross lesion score of the carpal joints. No significant correlation was present between the serum measures, osteocalcin and hydroxyapatite binding capacity of serum osteocalcin, and the bone measures, relative bone density distribution and joint gross lesion score.

Effect of dietary vitamin E supplementation on the integrity of skeletal muscle in exercised horses.

The effect of vitamin E intake on indicators of muscle integrity was studied in exercised horses. Nineteen horses were blocked by sex and then assigned to one of three diets: no supplemental vitamin E (BASAL), BASAL plus 80 IU of supplemental vitamin E/kg DM (80), or BASAL plus 300 IU of supplemental vitamin E/kg DM (300). The BASAL diet contained less than 44 IU of vitamin E/kg DM, but it was adequate in all other nutrients. During the 90-d treatment period, horses were exercised 5 d/wk; in addition, serum and middle gluteal muscle alpha-tocopherol concentrations were measured at 0, 30, and 90 d. All horses performed a repeated submaximal exercise test (RSET) at the end of the 90-d period. The following were measured before and after the RSET: alpha-tocopherol, thiobarbituric acid reactive substances (TBARS), conjugated diene (CD) concentrations of the middle gluteal muscle, and serum creatine kinase (CK) and aspartate aminotransferase (AST) activities. Serum alpha-tocopherol concentrations of horses receiving the BASAL and 80 diets decreased (P < .05 and P < .06, respectively) during the 90-d treatment period but did not change in horses receiving the 300 diet. Serum and muscle alpha-tocopherol concentrations were higher (P < .05) at 30 and 90 d in horses receiving the 300 diet than in horses receiving the BASAL and 80 diets. Serum CK and AST activities increased (P < .05) following RSET but were not affected by dietary vitamin E level. Muscle alpha-tocopherol level did not affect muscle CD or TBARS.

The effect of added dietary soybean oil on vitamin E status of the horse.

Fourteen 2-yr-old Quarter Horses and Quarter Horse x Thoroughbreds were randomly assigned to either a control (CTRL) diet or a diet supplemented with 6.4% soybean oil (SBO). The amounts of both diets that were fed met current NRC nutrient requirements and were isoenergetic with similar nutrient:energy ratios. Venous blood samples (20 mL) were taken at d 0, 30, 60, and 90 of the experiment and analyzed for serum alpha-tocopherol, serum cholesterol, and serum triglyceride. The sum of serum cholesterol and serum triglyceride values was used as an estimate of serum total lipid. The ratio of serum alpha-tocopherol:serum total lipid was used as a measure of vitamin E status of horses. The SBO group had higher serum cholesterol concentrations (P < .001) at 30, 60, and 90 d. Serum triglyceride was not affected by diet. Serum total lipids tended to be greater (P < .06) for the SBO group. Serum alpha-tocopherol was greater (P < .001) at 90 d in the SBO group. There was a significant correlation (P < .001, r = .62) between serum total lipids and serum alpha-tocopherol concentrations in the SBO group. This correlation was not significant (P < .07, r = .35) in the CTRL group. The ratio of serum alpha-tocopherol:serum total lipid was not affected by diet. The results of this experiment suggest that vitamin E status in non-exercising, 2-yr-old horses fed currently recommended levels of vitamin E was not affected by the addition of 6.4% SBO to the diet.